Literature Watch
Value of 24- to 48-Hour Infarct Volume as a Surrogate for Clinical Outcome in Late-Window Thrombectomy May be Limited: A Post Hoc Analysis of the AURORA Collaboration
Written By: NCS Staff
The 24‑ to 48‑hour follow‑up infarct volume (FIV) is a limited surrogate outcome for late–time‑window stroke because it explains only a...
Literature Watch
Stress Hyperglycemia Ratio and Adverse Outcomes in Acute Mild Ischemic Stroke or High-Risk Transient Ischemic Attack: A Secondary Analysis of the INSPIRES Trial
Written By: NCS Staff
New research shows that elevated stress hyperglycemia ratio (SHR) levels independently predict worse outcomes in patients with mild ischemic...
Literature Watch
Tenecteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: A Meta-Analysis of Randomized Controlled Trials
Written By: NCS Staff
In patients presenting with acute ischemic stroke who are treated within 4.5 to 24 hours of symptom onset, tenecteplase (TNK) significantly...
Literature Watch
Risk of Early Recurrent Stroke and Thrombotic Events After Reperfusion Therapy in Acute Ischemic Stroke: A Meta-Analysis
Written By: NCS Staff
Reperfusion therapies, when administered to patients experiencing an acute ischemic stroke up to 24 hours after symptom onset, did not lead to a...
Literature Watch
Dynamic Nomogram for Predicting Early Tracheotomy in Patients Diagnosed with Supratentorial Deep Seated Intracranial Hemorrhage
Written By: NCS Staff
Researchers developed and validated a dynamic nomogram prediction model to identify the early need for tracheotomy (TT) in patients with...
Literature Watch
Endovascular Thrombectomy Versus Best Medical Therapy for Large Vessel Occlusion Stroke Beyond 24 Hours: A Systematic Review and Meta-Analysis
Written By: NCS Staff
Researchers assessed the effectiveness of endovascular thrombectomy (EVT) in patients with acute ischemic stroke treated more than 24 hours after...
Literature Watch
Efficacy of Tenecteplase in Large Vessel Occlusion Stroke Within 24 Hours of Symptom Onset: The ETERNAL-LVO Randomized Controlled Trial
Written By: NCS Staff
The Phase III ETERNAL-LVO trial evaluated tenecteplase 0.25 mg/kg versus standard care in patients with large vessel occlusion and salvageable...
Literature Watch
The Association of Fluid Balance with Traumatic Brain Injury Outcomes: A Systematic Review
Written By: NCS Staff
A systematic review examined the effects of fluid volume management on outcomes in patients with moderate to severe traumatic brain injury (TBI).